Company intelligence / Profile preview

Emerald Health Naturals

Victoria, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Emerald Health Naturals commercializes natural health supplements targeting the endocannabinoid system, with products for cognition, stress, sleep, and inflammation. Its proprietary PhytoCann Complex is plant-derived, non-cannabis, and marketed as providing endocannabinoid system support. No formal clinical trial data available; product efficacy is supported by user feedback and nutraceutical market success

Therapeutic areas: OtherNeurologyRheumatologyPsychiatry
Modalities: Small molecule (botanical extracts, non-cannabis plant bioactives, vitamins, minerals)Nutritional supplement
Industry: Food & Nutrition

Partnerships

Emerald Health TherapeuticsEmerald Health BioceuticalsGAB Innovations (asset acquisition)Avricore Pharmaceuticals (distribution)

Beyond the preview

Go deeper on Emerald Health Naturals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerald Health Naturals.

Explore the full profile